chr2-101697929-C-CCCG
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001395002.1(MAP4K4):c.-140_-138dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.28 ( 6482 hom., cov: 15)
Exomes 𝑓: 0.23 ( 1419 hom. )
Consequence
MAP4K4
NM_001395002.1 5_prime_UTR
NM_001395002.1 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
MAP4K4 (HGNC:6866): (mitogen-activated protein kinase kinase kinase kinase 4) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-101697929-C-CCCG is Benign according to our data. Variant chr2-101697929-C-CCCG is described in ClinVar as [Benign]. Clinvar id is 1238946.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.477 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP4K4 | NM_001395002.1 | c.-140_-138dup | 5_prime_UTR_variant | 1/33 | ENST00000324219.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP4K4 | ENST00000324219.9 | c.-140_-138dup | 5_prime_UTR_variant | 1/33 | 5 | NM_001395002.1 | P3 | ||
MAP4K4 | ENST00000350878.9 | c.-140_-138dup | 5_prime_UTR_variant | 1/31 | 1 | ||||
MAP4K4 | ENST00000427603.5 | c.-5-135_-5-133dup | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.282 AC: 40908AN: 144976Hom.: 6481 Cov.: 15
GnomAD3 genomes
AF:
AC:
40908
AN:
144976
Hom.:
Cov.:
15
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.227 AC: 11488AN: 50658Hom.: 1419 Cov.: 4 AF XY: 0.226 AC XY: 5924AN XY: 26238
GnomAD4 exome
AF:
AC:
11488
AN:
50658
Hom.:
Cov.:
4
AF XY:
AC XY:
5924
AN XY:
26238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.282 AC: 40895AN: 145068Hom.: 6482 Cov.: 15 AF XY: 0.285 AC XY: 20096AN XY: 70502
GnomAD4 genome
AF:
AC:
40895
AN:
145068
Hom.:
Cov.:
15
AF XY:
AC XY:
20096
AN XY:
70502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at